Sagentia Limited Company Profile

19:51 EDT 19th March 2018 | BioPortfolio

Medical devices, diagnostics, therapeutics and drug delivery systems are becoming increasingly sophisticated, yet there is also growing pressure to control healthcare expenditures. For product manufacturers this means innovation must be combined with clinical effectiveness, delivered at the right cost to enable reimbursement and funding.

We have focused on the medical and healthcare sector for 20 years and throughout this time have put clinical and cost effectiveness at the forefront of our work. Today, our clients include some of the world’s leading medical technology and life science businesses. Our knowledge and insights into relevant technologies and business domains have led to many achievements for our clients, including:

Development of key breakthrough products and technologies – from complex technologies for the acute care device market to award-winning medical products for home healthcare, our solutions combine clinical utility and cost effectiveness

Understanding customer needs and market requirements – from a cardiac catheterisation lab to home blood testing, our deep knowledge of stakeholder needs has been used to aid successful product innovation

Improved business strategies and innovation performance – technology know-how, combined with a disease-centred view, allow us to address key business concerns effectively. Recent assignments have included the identification of disruptive technologies and opportunity discovery. Typical outcomes are the protection of an organisation’s core business and the identification of clinical areas with high growth potential.


Harston Mill
CB22 7GG
United Kingdom


Phone: 00 44 1223 875200
Fax: 00 44 1223 875201

News Articles [30 Associated News Articles listed on BioPortfolio]

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Quotient Limited to Participate in the 36th Annual J.P. Morgan Healthcare Conference

JERSEY, Channel Islands, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [83 Associated Companies listed on BioPortfolio]

Sagentia Inc.

Sagentia is a global innovation, technology and product development company. We provide outsourced R&D consultancy services to start ups through to global market leaders in the me...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Sagentia Limited

Medical devices, diagnostics, therapeutics and drug delivery systems are becoming increasingly sophisticated, yet there is also growing pressure to control healthcare expenditures. For product manufa...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...


More Information about "Sagentia Limited" on BioPortfolio

We have published hundreds of Sagentia Limited news stories on BioPortfolio along with dozens of Sagentia Limited Clinical Trials and PubMed Articles about Sagentia Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sagentia Limited Companies in our database. You can also find out about relevant Sagentia Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record